Home > PE Ratio > GENPHARMASEC

GENPHARMASEC
PE (Price/Earnings) Ratio

The Current P/E Ratio of GENPHARMASEC is 47.20.

Share Price ₹2.3Feb 12,2025
Market Cap ₹125.7 Cr
Earnings-TTM₹2.7 CrTTM-Standalone Results
Price/Earnings47.20xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of GENPHARMASEC

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of GENPHARMASEC is calculated as :

Current Market Cap [ ₹125.7 Cr] as on Feb 12,2025

(/) Earnings [ ₹2.7 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 47.20x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for GENPHARMASEC , the investors are currently willing to pay 47.20 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of GENPHARMASEC !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of GENPHARMASEC over the last five years.

Historical PE (Price/Earnings) ratio chart of GENPHARMASEC


PE Ratio Performance Analysis for GENPHARMASEC

- GENPHARMASEC 's latest p/e ratio is 47.20x.

- GENPHARMASEC 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 649.97x.

- GENPHARMASEC 's operated at median p/e ratio of 138.15x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, GENPHARMASEC 's p/e ratio peaked in Mar2024 at 2787.5x.

- GENPHARMASEC 's p/e ratio hit its five-year low in Mar2022 of 0x.


How does GENPHARMASEC 's P/E Ratio benchmark against top 10 peers in Dyes & Pigments Industry?

Peer Comparison (Dyes & Pigments Industry)Earnings-TTM (Cr)PE RatioMarket Cap
GENPHARMASEC 2.6647.20125.7
SUDARSHAN CHEMICAL INDUSTRIES LTD131.9657.227,550.5
VIDHI SPECIALTY FOOD INGREDIENTS LTD41.9854.842,302.0
KIRI INDUSTRIES LTD-60.88-53.453,253.7
BODAL CHEMICALS LTD6.04136.33823.3
BHAGERIA INDUSTRIES LTD29.9426.19784.1
SHREE PUSHKAR CHEMICALS & FERTILISERS LTD55.1717.40960.1
ASAHI SONGWON COLORS LTD10.8930.01326.9
PODDAR PIGMENTS LTD26.4213.14347.3
DYNEMIC PRODUCTS LTD15.1223.78359.6
VIPUL ORGANICS LTD4.0667.08272.4

Dyes & Pigments Industry Benchmark (Top 10) PE Analysis vs GENPHARMASEC 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE -53.45x
Max industry PE 136.33x
Median industry PE 30.01x
Average industry PE 38.16x



You may also like the below Video Courses